Intervention not reported
All‐cause mortality (ticlopidine vs placebo) · patients with type 2 diabetes mellitus
The intervention showed no clear difference in all‐cause mortality (ticlopidine vs placebo) (moderate certainty).
1 finding from 1 review
- Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes… 2012 · Cochrane Headline outcomes onlyRR 1.29 [0.71, 2.32]1 study · 335 participantsModerate